fda tirzepatide news Huge news: has approved Zepbound (tirzepatide- GLP-1/GIP receptor agonist) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. As a cardiologist, this is a huge deal BREAKING NEWS: Judge Grills FDA

Dehydration, insufficient sleep, and high stress can amplify nausea and digestive discomfort, making lifestyle factors just as important as medication variables during your first month of treatment

[2][3] Apotex began shipping to Canadian pharmacies on May 20, 2026, with Shoppers Drug Mart, Rexall, Costco Pharmacy and Walmart receiving the first inventory

2007;77(Suppl 1):S2638

Inflammation and Cellular Signaling Inflammation is a natural part of the bodys response to injury, but excessive or prolonged inflammation can interfere with recovery

Serious side effects are rare but can include severe allergic reactions, low magnesium levels, and bone fractures